REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
|Articles|August 15, 2022
Daily OTC Pearl of the Day: Campho-Phenique
Author(s)Saro Arakelians, PharmD
Campho-Phenique is an antiseptic liquid indicated for the treatment of insect bites, minor skin irritations, and minor burns.
Advertisement
OTC/Lifestyle Pearl of the Day: Campho-Phenique
Indication: Campho-Phenique can be used for relief from pain and itch and is indicated for the treatment of insect bites, minor skin irritations, and minor burns.
Insight:
- Campho-Phenique is an antiseptic liquid used for temporary relief from pain and itching.
- Directions: Campho-Phenique can be used in adults and children aged 2 years and over. The affected area should be cleaned first before applying a small amount of the product on the area 1 to 3 times daily; however, do not bandage. Before use in children aged under 2 years of age, a doctor should be consulted. Store Campho-Pheniqueat room temperature. Avoid excessive heat above 40 degrees C (104 degrees F). Close cap tightly after use.
- Active Ingredients: Camphorated Phenol (Camphor 10.8% and Phenol 4.7%)
Reference:
Advertisement
Related to this article
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Advertisement
Advertisement